Hospital News and Research

RSS

New survey reveals public attitudes towards commercial use of genetic data samples

The almost 5 million people who paid to get their DNA analyzed by the company 23andMe recently found out that their genetic data and related health information might have been sold to a major drug company.

31 Aug 2018

Research may hold key to unlocking cause and finding treatment for age-related hearing loss

Age-related hearing loss is among the top three chronic conditions affecting adults 65 years or older, according to the National Center for Health Statistics.

31 Aug 2018

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

A $2 million phase 2 Small Business Technology Transfer grant to optimize a promising new compound that has shown efficacy in preclinical studies against treatment-resistant multiple myeloma has been awarded to a Medical University of South Carolina startup company, Leukogene Therapeutics, Inc., in collaboration with MUSC researcher and company founder, Nathan G. Dolloff, Ph.D. Dolloff is an assistant professor in the Department of Cell and Molecular Pharmacology & Experimental Therapeutics at MUSC and a member of MUSC Hollings Cancer Center.

31 Aug 2018

Study raises possibility of detecting childhood bone cancers earlier

Scientists have discovered that some childhood bone cancers start growing years before they are currently diagnosed.

30 Aug 2018

TGHRI scientists detail role of insulin as a boost to the immune system

The role of insulin as a boost to the immune system to improve its ability to fight infection has been detailed for the first time by Toronto General Hospital Research Institute scientists.

30 Aug 2018

Stigmatizing views, false perceptions about psoriasis continue to persist among people in the U.S.

The stigma associated with the autoimmune disease psoriasis may lead people to avoid patients who show signs of the condition, including not wanting to date, shake hands, or have people in their homes if they suffer from the disease.

30 Aug 2018

New genetic marker could improve diagnosis of prostate cancer

Scientists have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and poorer survival rates of patients.

30 Aug 2018

Immunization shots effective at preventing measles

High fever. Cough. Runny nose. Red, watery eyes. It may not be the flu. It could be measles.

30 Aug 2018

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

Shionogi & Co., Ltd. announced today that Mulpleta (lusutrombopag), a once-daily, orally administered, small molecule thrombopoietin (TPO) receptor agonist for the treatment of thrombocytopenia in adult patients with chronic liver disease (CLD) who are scheduled to undergo a procedure, is now available throughout the United States.

30 Aug 2018

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

30 Aug 2018

Ultralaser treatment reduces pain in patients with fibromyalgia

A new device that combines low-intensity laser light and therapeutic ultrasound considerably reduces the pain experienced by patients with fibromyalgia.

30 Aug 2018

$Genetics study uncovers key factors for fracture risk in osteoporosis$

Genetics study uncovers key factors for fracture risk in osteoporosis

The largest study ever to investigate the genetics of osteoporosis and fracture risk determined that only two examined factors - bone mineral density and muscle strength - play a potentially causal role in the risk of suffering osteoporotic fracture, a major health problem affecting more than 9 million people worldwide very year.

30 Aug 2018

Study: First independent in-home use of brain-computer interface by ALS patients shows promise

Laboratory studies have shown the potential for patients with amyotrophic lateral sclerosis, who cannot move or speak, to communicate using a brain-computer interface.

30 Aug 2018

Monell Center and Jefferson sign Agreement of Cooperation to improve human health

The Monell Center and Jefferson (Philadelphia University and Thomas Jefferson University) announced today the signing of an Agreement of Cooperation, outlining how the two institutions will collaborate over the next year to develop joint scientific programs and clinical opportunities to advance their shared mission of improving human health.

30 Aug 2018

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

Two UH researchers have won a five-year, $3.5 million grant from the National Institute of Allergy and Infectious Diseases to develop technology that will quickly suggest the most promising combinations of antibiotics to kill certain resistant bacteria.

30 Aug 2018

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

A promising drug slowed brain shrinkage in progressive multiple sclerosis (MS) by nearly half, according to new research led by Cleveland Clinic. Very limited therapies are currently available for this disabling form of the disease.

30 Aug 2018

SMA treatment may be effective even if started in children seven months and older

A drug shown to be effective in the treatment of babies with the rare muscle-wasting disease spinal muscular atrophy may be effective for muscle control even when treatment is started in children seven months and older, according to a study published in the August 29, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. Previous studies focused on children younger than seven months old.

30 Aug 2018

TTUHSC El Paso's colorectal cancer initiative catches the eye of National Cancer Institute

A Texas Tech University Health Sciences Center El Paso initiative that is increasing the number of screenings for colorectal cancer across West Texas has caught the eye of the National Cancer Institute.

30 Aug 2018

Clinical trial provides 'strong signal' that TAVR is safe for patients with low surgical risk

Results of a clinical trial using transcatheter aortic valve replacement provided a "strong signal" that it is safe for patients with low surgical risk, potentially helping to open the way for broader use of the minimally invasive procedure, also known as TAVR.

30 Aug 2018

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Two Texas-based nonprofits, Candlelighters of El Paso and the Light and Salt Association, have been named the recipients of the American Society for Radiation Oncology2018 Survivor Circle grants. Each organization will receive a $10,000 grant to aid their cancer support programs and will be recognized at an award ceremony on October 23 during ASTRO's 60th Annual Meeting in San Antonio.

30 Aug 2018

Hospital News and Research

New survey reveals public attitudes towards commercial use of genetic data samples

Research may hold key to unlocking cause and finding treatment for age-related hearing loss

Leukogene receives STTR grant to optimize compound for treatment-resistant multiple myeloma

Study raises possibility of detecting childhood bone cancers earlier

TGHRI scientists detail role of insulin as a boost to the immune system

Stigmatizing views, false perceptions about psoriasis continue to persist among people in the U.S.

New genetic marker could improve diagnosis of prostate cancer

Immunization shots effective at preventing measles

Shionogi launches Mulpleta in the U.S for safe, effective treatment of thrombocytopenia

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Ultralaser treatment reduces pain in patients with fibromyalgia

Genetics study uncovers key factors for fracture risk in osteoporosis

Study: First independent in-home use of brain-computer interface by ALS patients shows promise

Monell Center and Jefferson sign Agreement of Cooperation to improve human health

UH researchers win $3.5 million grant to develop technology that combats multi-drug resistant bacteria

Clinical trial: Promising drug slows brain shrinkage in progressive MS patients

SMA treatment may be effective even if started in children seven months and older

TTUHSC El Paso's colorectal cancer initiative catches the eye of National Cancer Institute

Clinical trial provides 'strong signal' that TAVR is safe for patients with low surgical risk

Two Texas-based nonprofits named as recipients of ASTRO 2018 Survivor Circle grants

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News